A Randomized Study of the Efficacy and Safety of OncoGel Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-Regional Esophageal Cancer.

Trial Profile

A Randomized Study of the Efficacy and Safety of OncoGel Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-Regional Esophageal Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Paclitaxel (Primary) ; Cisplatin; Fluorouracil
  • Indications Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Nov 2016 Results published in the Gastrointestinal Endoscopy
    • 10 May 2011 Results presented at Digestive Disease Week 2011.
    • 05 Apr 2011 Status changed from active, no longer recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top